The FDA’s Ongoing Crackdown on Unauthorized Vape Sales

The vaping industry is facing increased scrutiny as the Food and Drug Administration (FDA) intensifies its fight against unauthorized vape sales. On September 23, the FDA announced fines against two brick-and-mortar retailers and nine online retailers, revealing its commitment to enforcing regulations concerning the sale of tobacco products. This decision follows prior warning letters issued to these retailers regarding the sale of unauthorized tobacco products, and subsequent inspections revealed that these violations had not been corrected.

Imposing Civil Money Penalties

The FDA is seeking a civil money penalty (CMP) of $20,678 from each retailer involved. These latest enforcement actions are part of a broader initiative; to date, the FDA has filed CMP complaints against 70 manufacturers and 160 retailers engaged in the distribution and sale of unauthorized tobacco products.

Firm Commitment to Regulation

In a recent statement, the FDA highlighted its continued dedication to enforcement actions against entities along the tobacco supply chain that violate the law. Currently, the FDA has authorized only 34 e-cigarette products and devices, and they maintain a printable one-page flyer that retailers can use to check which products are lawfully marketed and sold in the United States.

Enhanced Enforcement Strategies

Throughout 2023, the FDA has amplified its enforcement efforts, especially related to e-cigarette products. Significantly, in June, the agency collaborated with the Department of Justice (DOJ) to form a new task force aimed specifically at curbing unauthorized vape sales.

Collaboration with Law Enforcement

The task force comprises various law enforcement agencies, including the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), the U.S. Marshals Service (USMS), the U.S. Postal Inspection Service (USPIS), and the Federal Trade Commission (FTC). Its objective is to coordinate and streamline efforts to address the illegal distribution and sale of e-cigarettes, which have been linked to nicotine addiction among American youth.

Areas of Focus for the Task Force

The federal task force aims to investigate and prosecute various issues, including:

• New criminal and civil actions under the PACT Act.
• Enforcement of the Federal Food, Drug, and Cosmetic Act (FDCA), particularly as amended by the Family Smoking Prevention and Tobacco Control Act (TCA).
• Exploration of other relevant legal authorities available to them.

Industry Impact: Permanent Injunctions

Just a week after the task force was announced, it made headlines by filing a permanent injunction against the vape manufacturer Boosted, which operates under names such as Boosted E-Juice and Live Boosted, alongside its owner, Cory Vigil. This action demonstrates the serious nature of the compliance efforts underway and sets a new precedent for the industry.

Statements from FDA Officials

Brian King, the director of the FDA’s Center for Tobacco Products (CTP), stated, “FDA remains steadfast in our work to enforce the law, especially after we’ve given a crystal-clear warning and explanation of what firms need to do to comply. Those who flout the law are responsible for the consequences, and we are committed to using the full force of our authorities to hold them accountable.” This emphasizes the importance of compliance and the repercussions for those who fail to adhere to regulations.

Staying Informed: Compliance Resources for Retailers

Now, more than ever, it is crucial for retailers to stay informed regarding the current status of vape products they sell. Retailers wishing to verify their compliance with regulations can utilize the FDA’s newly launched Searchable Tobacco Products Database, which offers an accessible way to check authorized products.

Conclusion

The FDA’s strict enforcement actions against unauthorized vape sales underline a significant shift in regulatory focus, particularly concerning youth nicotine addiction. Retailers and manufacturers alike must prioritize compliance to navigate the evolving landscape of vape product regulations successfully. With the FDA’s enhanced focus and collaboration with various law enforcement agencies, the industry must remain vigilant to adhere to the law and avoid financial penalties.